{"gene":"CDKN1A","run_date":"2026-06-09T22:57:18","timeline":{"discoveries":[{"year":1993,"finding":"WAF1/p21 is a direct transcriptional target of wild-type p53: a p53-binding site was identified 2.4 kb upstream of WAF1 coding sequences, and the WAF1 promoter conferred p53-dependent inducibility upon a heterologous reporter gene. Introduction of WAF1 cDNA suppressed growth of human tumor cells in culture.","method":"Yeast enhancer trap, promoter-reporter assay, cDNA overexpression in human tumor cell lines","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (enhancer trap, reporter assay, functional cDNA suppression), foundational paper replicated by the field","pmids":["8242752"],"is_preprint":false},{"year":1995,"finding":"p21Cip1 contains two functionally independent cell-cycle inhibitory domains: an N-terminal CDK-inhibitory domain and a C-terminal PCNA-binding/inhibitory domain. When separately overexpressed in mammalian cells, each domain independently prevents DNA replication.","method":"Domain deletion/overexpression in mammalian cells, in vitro PCNA-dependent DNA replication assay, CDK inhibition assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution assay combined with domain mutagenesis and in vivo overexpression, replicated across multiple labs","pmids":["7753174"],"is_preprint":false},{"year":1994,"finding":"p21/WAF1/CIP1 can be induced through a p53-independent pathway: serum and growth factors (PDGF, FGF, EGF but not insulin) induce WAF1 in quiescent p53-deficient fibroblasts as an immediate-early gene, whereas DNA damage (gamma-irradiation) induces WAF1 via a p53-dependent pathway.","method":"p53 knockout mouse embryonic fibroblasts, growth factor stimulation, gamma-irradiation, mRNA kinetics with cycloheximide","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (p53-null cells) combined with multiple stimuli and kinetic analysis; independently confirmed by other labs","pmids":["8012956"],"is_preprint":false},{"year":1995,"finding":"p21Cip1 is expressed in a p53-independent manner during terminal differentiation of multiple cell lineages (skeletal muscle, cartilage, skin, nasal epithelium). MyoD is sufficient but not necessary for p21 induction in myogenic cells, as p21 is still expressed in MyoD/myogenin double-knockout mice.","method":"p53 knockout and MyoD/myogenin knockout mice, in situ hybridization, expression analysis during development","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic knockouts combined with expression analysis in multiple tissues; widely replicated","pmids":["7863329"],"is_preprint":false},{"year":2001,"finding":"Akt phosphorylates p21Cip1/WAF1 at threonine 145, resulting in cytoplasmic localization of p21 and promotion of cell growth. HER-2/neu-mediated activation of Akt drives this phosphorylation; blocking Akt with dominant-negative Akt restores nuclear localization and growth-inhibiting activity of p21.","method":"Co-IP, dominant-negative Akt expression, phosphorylation assay, subcellular fractionation/immunofluorescence, HER-2/neu-overexpressing cell lines","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, dominant-negative rescue, direct phosphorylation mapping, multiple orthogonal methods in single study","pmids":["11231573"],"is_preprint":false},{"year":1996,"finding":"p21Cip1/WAF1 competes with Fen1 for binding to PCNA: p21 binds PCNA with Kd ~10 nM (3 molecules per PCNA trimer) and prevents formation of a PCNA-Fen1 complex, thereby disrupting Fen1 recruitment to the DNA replication complex. Overexpression of p21 disrupts Fen1-PCNA interaction in vivo.","method":"In vitro binding assay (Kd measurement), co-immunoprecipitation in cell extracts, overexpression in vivo","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative in vitro binding assay plus in vivo co-IP and overexpression validation, single lab with multiple orthogonal methods","pmids":["8876181"],"is_preprint":false},{"year":2002,"finding":"Pim-1 kinase associates with p21Cip1/WAF1 and phosphorylates it at Thr145 in vivo, resulting in cytoplasmic localization of p21. Co-transfection of kinase-dead Pim-1 results in nuclear localization of p21, whereas wild-type Pim-1 drives cytoplasmic localization.","method":"In vitro kinase assay, pull-down assay, immunoprecipitation, co-transfection with wild-type and kinase-dead Pim-1, phosphoamino acid analysis, subcellular localization","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with site identification, confirmed in vivo by co-transfection rescue and subcellular localization, multiple methods in single lab","pmids":["12431783"],"is_preprint":false},{"year":2000,"finding":"p21cip1/waf1 functions as the molecular switch governing hematopoietic stem cell (HSC) quiescence: p21-knockout mice show increased HSC proliferation and number under homeostasis, and serial transplantation of p21-/- bone marrow leads to HSC exhaustion and hematopoietic failure under stress.","method":"p21 knockout mice, serial bone marrow transplantation, cell cycle analysis, myelotoxic injury model","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic knockout with specific in vivo phenotypic readouts, serial transplantation, widely cited and replicated","pmids":["10710306"],"is_preprint":false},{"year":1997,"finding":"p21CIP1 mediates G1-S cell cycle arrest downstream of the homeodomain protein Gax: Gax overexpression induces p53-independent upregulation of p21, leading to p21 association with cdk2 complexes and decreased cdk2 activity. Fibroblasts deficient in p21 are not susceptible to growth inhibition or cdk2 inactivation by Gax.","method":"Recombinant adenovirus-mediated Gax overexpression, p21 knockout fibroblasts, cdk2 activity assay, co-immunoprecipitation","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (p21-null cells) combined with biochemical CDK assay and co-IP, single lab","pmids":["9224717"],"is_preprint":false},{"year":1997,"finding":"p21CIP1 and Cdc25A compete for binding to cyclin-cdk complexes via a cyclin-binding Cy motif. A p21-derived Cy-motif peptide competitively disrupts Cdc25A-cyclin-cdk2 association and inhibits cdk2 dephosphorylation. p21 inhibits Cdc25A-mediated cyclin E-cdk2 association, while Cdc25A protects cyclin-cdk from p21 inhibition.","method":"In vitro binding assay, Cy-motif mutagenesis, competitive peptide inhibition, Xenopus egg extract DNA replication assay, co-immunoprecipitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with mutational analysis and competitive peptide, plus Xenopus extract assay, multiple orthogonal methods","pmids":["9234691"],"is_preprint":false},{"year":2000,"finding":"c-Myc directly binds the C-terminal region of p21 and partially relieves p21-mediated inhibition of PCNA-dependent DNA polymerase delta activity. Conversely, p21 binding to the Myc box II region of c-Myc blocks c-Myc-Max complex formation on E-box elements, suppressing c-Myc transcriptional activation.","method":"Co-immunoprecipitation, in vitro DNA synthesis assay, electrophoretic mobility shift assay (EMSA), transcription reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus functional biochemical assays (DNA synthesis, EMSA), single lab","pmids":["10744738"],"is_preprint":false},{"year":2005,"finding":"SCF(Skp2) ubiquitin ligase ubiquitinates p21Cip1/WAF1 in a manner that requires functional interaction of p21 with the cyclin E-Cdk2 complex. Mutation of both the cyclin E recruitment motif (RXL) and the Cdk2-binding motif (FNF) at the N-terminus of p21 abolishes ubiquitination; ubiquitination occurs at four C-terminal lysine residues.","method":"In vitro ubiquitination assay, site-directed mutagenesis of p21, co-immunoprecipitation, in vivo ubiquitination assay","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstituted ubiquitination assay with mutagenesis of substrate recruitment motifs and ubiquitination sites, confirmed in vivo","pmids":["16262255"],"is_preprint":false},{"year":2009,"finding":"p21Cip1/WAF1 mediates DNA damage-induced G2 cell cycle arrest by promoting proteasomal degradation of cyclin B1. Cells lacking p21 or unable to upregulate p21 fail to downregulate cyclin B1 after DNA damage, cannot sustain G2 arrest, and accumulate >4N DNA content.","method":"p21-null cells, DNA damage treatment, cyclin B1 protein level analysis, proteasome inhibitor rescue, cell cycle analysis","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (p21-null) combined with pharmacological rescue (proteasome inhibitor), single lab","pmids":["19158493"],"is_preprint":false},{"year":2007,"finding":"p21(Waf1) promotes proteasomal degradation of the retinoblastoma protein Rb in a p53-independent manner: ectopic p21 in HT1080 and HCT116 cells causes both Rb dephosphorylation (activation) and Rb protein depletion via proteasome. Rb depletion after DNA damage does not occur in the absence of p21.","method":"Ectopic p21 expression, p53-independent context, proteasome inhibitor, p21 shRNA knockdown, transdominant p53 inhibitor","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell lines, pharmacological (proteasome inhibitor) and genetic (shRNA) approaches, single lab","pmids":["17486059"],"is_preprint":false},{"year":2013,"finding":"Lats2 kinase phosphorylates p21/CDKN1A at S146 in response to UV irradiation (after being activated by Chk1 phosphorylation at S835). This phosphorylation induces degradation of p21, releases procaspase-3 inhibition, and promotes apoptosis via caspase-3 and caspase-9 activation.","method":"In vitro kinase assay, site-directed mutagenesis, UV irradiation, caspase activity assay, overexpression and knockdown","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with site identification plus functional apoptosis readout, single lab","pmids":["23886938"],"is_preprint":false},{"year":2016,"finding":"Cdk1/cyclin B1 phosphorylates p21 at S130 during mitosis, which reduces p21 stability and its binding affinity to Cdk1/cyclin B1. Interfering with this phosphorylation (S130A mutant) results in extended mitotic duration and defective chromosome segregation.","method":"In vitro kinase assay, S130A phospho-mutant expression, mitotic duration measurement, chromosome segregation analysis","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with phospho-site mutagenesis and functional mitotic readout, single lab","pmids":["27384476"],"is_preprint":false},{"year":2016,"finding":"Cdk5 directly phosphorylates p21CIP1 at S130 in a Cdk2-independent manner, triggering proteasome-dependent degradation of nuclear p21 primarily in S-phase and promoting cancer cell growth. S130A-p21 mutant blocks both p21 degradation and Cdk5-induced cancer cell growth increase.","method":"In vitro kinase assay, S130A mutant, proteasome inhibitor, cell growth assay, subcellular fractionation, clinical sample correlation","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional growth assay, single lab","pmids":["27909065"],"is_preprint":false},{"year":2004,"finding":"BRG1-containing SWI/SNF complexes activate pRb by inducing its hypophosphorylation through upregulation of p21CIP1/WAF1/SDI1. The physical interaction between BRG1 and pRb is not required for cell growth arrest or E2F target gene repression; instead, BRG1 acts via p21 induction to activate pRb. p21 upregulation by BRG1 is necessary to induce growth arrest and cell senescence.","method":"BRG1 expression in cells, p21 promoter analysis, CDK2/cyclin E/cyclin D measurement, cell senescence assay, growth arrest assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional epistasis via expression and genetic approaches, single lab with multiple phenotypic readouts","pmids":["14729964"],"is_preprint":false},{"year":2009,"finding":"CTIP2 recruits histone deacetylases and the methyltransferase SUV39H1 to the p21(WAF1) promoter, silencing p21 transcription via H3K9 trimethylation. Inhibition of SUV39H1 with chaetocin reduces H3K9me3 at the p21 promoter and stimulates p21 expression.","method":"ChIP assay, SUV39H1 inhibitor treatment, promoter reporter assay, co-immunoprecipitation of CTIP2 with HDACs and SUV39H1","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating recruitment, pharmacological inhibitor, and reporter assay, single lab","pmids":["19581932"],"is_preprint":false},{"year":2004,"finding":"Proteinase 3 (PR3) cleaves p21 between Thr80 and Gly81 in endothelial cells, causing loss of nuclear p21, cytoplasmic sequestration, and depletion of p21 from cyclin/CDK complexes, thereby promoting endothelial cell apoptosis. Granzyme B cleaves p21 at a different site (between Asp62 and Phe63).","method":"Immunoblotting, immunofluorescence, flow cytometry, treatment of HUVECs with PR3, cleavage site mapping","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cleavage with site identification, functional loss-of-nuclear-localization and apoptosis readout, single lab","pmids":["14675038"],"is_preprint":false},{"year":2005,"finding":"Mitf (microphthalmia-associated transcription factor) activates p21(Cip1) gene expression and induces G1 cell-cycle arrest in a p21-dependent manner. Cooperation between Mitf and retinoblastoma protein Rb1 potentiates Mitf-mediated transcriptional activation. Mitf-mediated p21 induction leads to Rb1 hypophosphorylation.","method":"Mitf overexpression, p21 promoter reporter assay, co-immunoprecipitation of Mitf with Rb1, cell cycle analysis","journal":"Nature","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter reporter, protein-protein interaction, and functional cell cycle assay, single lab","pmids":["15716956"],"is_preprint":false},{"year":1999,"finding":"Ras induces p21Cip1/Waf1 transcriptionally through Sp1-binding sites (positions -83 to -54) in the p21 promoter. Mutation of both Sp1-binding sites 2 and 4 abolishes Ras-induced promoter activity. In conditional Ras-expressing cells, p21 induction is posttranscriptional via the MAPK pathway.","method":"Conditional Ras expression, p21 promoter deletion and point mutants, luciferase reporter, EMSA for Sp1/Sp3 binding","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter mutagenesis with EMSA confirmation, two model systems, single lab","pmids":["10597223"],"is_preprint":false},{"year":2003,"finding":"GADD34 promotes p53 phosphorylation at Ser15 in a dose-dependent manner and enhances p21/WAF1 transcription via p53-dependent activation of the p21 promoter. p21 promoter activity is very low in GADD34-deficient MEFs and is restored by GADD34 transfection.","method":"GADD34 transfection, p53 phosphorylation assay (Ser15), p21 promoter-reporter assay, GADD34-deficient MEFs","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic (GADD34-null MEFs) and biochemical (phosphorylation assay, reporter assay), single lab","pmids":["14635196"],"is_preprint":false},{"year":2021,"finding":"NSUN2-mediated m5C modification of CDKN1A mRNA promotes its nuclear export via the ALYREF m5C reader, thereby upregulating p21 protein expression. NSUN2 deficiency reduces ALYREF recognition of CDKN1A mRNA, decreases mRNA export to cytoplasm, reduces p21 translation, accelerates cell cycle, and promotes adipogenesis.","method":"NSUN2 knockdown, RIP (RNA immunoprecipitation) for ALYREF-CDKN1A mRNA interaction, mRNA nuclear/cytoplasmic fractionation, Western blot, cell cycle analysis","journal":"RNA biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP demonstrating direct ALYREF-CDKN1A mRNA interaction, fractionation showing export defect, functional rescue, single lab","pmids":["34570675"],"is_preprint":false},{"year":2012,"finding":"Trim71 associates with Argonaute2 and microRNAs and represses Cdkn1a expression, promoting the G1-S transition in embryonic stem cells. Trim71 knockdown prolongs G1 phase and slows ESC proliferation; this phenotype is rescued by Cdkn1a depletion, placing Trim71 upstream of Cdkn1a in the ESC cell cycle regulatory pathway.","method":"Co-immunoprecipitation of Trim71 with Ago2, Trim71 knockdown, Cdkn1a reporter assay, cell cycle analysis, epistasis rescue by Cdkn1a depletion","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis rescue, co-IP with Ago2, and cell cycle phenotype, single lab","pmids":["22735451"],"is_preprint":false},{"year":2016,"finding":"CDKN1A/p21 is required for Langerhans cell (LC) survival and DNA repair after ionizing radiation (IR). Cdkn1a-/- LCs undergo apoptosis and accumulate DNA damage after IR, and fail to upregulate MHC class II, migrate to draining lymph nodes, or induce Treg cell accumulation, unlike wild-type LCs.","method":"Cdkn1a-/- mice, IR treatment, apoptosis assay, DNA damage markers, MHC class II expression, lymph node migration assay, Treg quantification","journal":"Nature immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with multiple specific phenotypic readouts (apoptosis, DNA repair, migration, Treg induction), single lab","pmids":["26343536"],"is_preprint":false},{"year":2020,"finding":"TFEB directly regulates basal and DNA damage-induced p21/WAF1 expression in a p53-dependent manner. TFEB depletion dramatically reduces basal p21 levels; TFEB overexpression increases p21 and delays G2/M arrest during doxorubicin-induced DNA damage, promoting cell survival. Pharmacological inhibition of p21 abrogates TFEB-mediated cell protection.","method":"TFEB knockdown and overexpression, p21 promoter reporter (implied by p53-dependent effect), doxorubicin treatment, cell cycle analysis, pharmacological p21 inhibition","journal":"Cells","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, overexpression/knockdown with functional readout but limited mechanistic detail in abstract; no direct ChIP or promoter binding shown","pmids":["32397616"],"is_preprint":false},{"year":1998,"finding":"A C-terminally truncated form of p21 (p21delta, lacking ~10 C-terminal amino acids including the PCNA-binding domain, second cyclin-binding domain, and NLS) is found in transformed cell lines and after high-dose UV. Unlike full-length p21, p21delta is not associated with Cdk2 or PCNA, is monomeric by gel filtration, and localizes predominantly to the cytoplasm rather than the nucleus.","method":"SDS-PAGE mobility shift analysis, co-immunoprecipitation with Cdk2 and PCNA, gel filtration chromatography, subcellular fractionation/immunofluorescence","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal biochemical methods (co-IP, gel filtration, fractionation) in single lab characterizing a naturally occurring p21 variant","pmids":["9546435"],"is_preprint":false}],"current_model":"CDKN1A/p21 is a multifunctional cyclin-dependent kinase inhibitor that is transcriptionally induced by p53 (in response to DNA damage) and by p53-independent pathways (growth factors, differentiation signals, MAPK, Mitf, BRG1, TFEB); it inhibits CDK activity through its conserved N-terminal domain, blocks PCNA-dependent DNA replication through its C-terminal domain (competing with Fen1 for PCNA binding), undergoes cytoplasm-promoting phosphorylation at Thr145 by Akt and Pim-1 (and at S130 by Cdk1, Cdk5, and Lats2 leading to proteasomal degradation), is ubiquitinated by SCF(Skp2) at C-terminal lysines in a cyclin E-Cdk2-dependent manner, mediates G1 and G2 cell cycle arrest (including cyclin B1 degradation), controls hematopoietic stem cell quiescence, and in the cytoplasm exerts anti-apoptotic functions, with its subcellular localization being a key determinant of whether it acts as a tumor suppressor or survival factor."},"narrative":{"mechanistic_narrative":"CDKN1A/p21 is a multifunctional cyclin-dependent kinase inhibitor that couples diverse anti-proliferative and stress signals to cell-cycle arrest, differentiation, and stem-cell quiescence [PMID:8242752, PMID:10710306]. It was first defined as a direct transcriptional target of wild-type p53, whose induction following DNA damage mediates growth suppression [PMID:8242752], but it is also induced through p53-independent routes—by serum and growth factors as an immediate-early gene [PMID:8012956], during terminal differentiation of multiple lineages [PMID:7863329], and by an array of transcriptional regulators including Ras/Sp1 [PMID:10597223], BRG1/SWI-SNF [PMID:14729964], Mitf [PMID:15716956], and GADD34-enhanced p53 activity [PMID:14635196]; its promoter is conversely silenced by CTIP2-recruited HDACs and SUV39H1-mediated H3K9 trimethylation [PMID:19581932]. p21 is built from two functionally separable inhibitory domains: an N-terminal CDK-inhibitory domain and a C-terminal PCNA-binding domain, each of which independently blocks DNA replication [PMID:7753174]. Through its N-terminal cyclin (Cy/RXL) and CDK-binding motifs it engages cyclin-CDK complexes—competing with Cdc25A for these complexes [PMID:9234691] and inactivating CDK2 downstream of inducers such as Gax [PMID:9224717]—while its C-terminal domain binds PCNA with nanomolar affinity and displaces Fen1 from the replication complex [PMID:8876181]. Beyond G1 control, p21 enforces DNA damage-induced G2 arrest by promoting proteasomal degradation of cyclin B1 [PMID:19158493] and is itself phosphorylated by Cdk1/cyclin B1 at S130 to ensure proper mitotic progression and chromosome segregation [PMID:27384476]. p21 abundance and localization are tightly regulated: SCF(Skp2) ubiquitinates it at C-terminal lysines in a cyclin E-CDK2-dependent manner [PMID:16262255], Akt and Pim-1 phosphorylate Thr145 to drive cytoplasmic relocalization and convert p21 into a growth/survival factor [PMID:11231573, PMID:12431783], Cdk5 and Lats2 phosphorylate S130/S146 to trigger its degradation [PMID:27909065, PMID:23886938], and proteolytic cleavage by proteinase 3 strips its nuclear localization and promotes apoptosis [PMID:14675038]. This localization control is the key determinant of whether p21 acts as a nuclear tumor suppressor or a cytoplasmic survival factor. Physiologically, p21 is the molecular switch governing hematopoietic stem cell quiescence, with its loss causing HSC over-proliferation and exhaustion under stress [PMID:10710306], and it supports Langerhans cell survival and DNA repair after irradiation [PMID:26343536].","teleology":[{"year":1993,"claim":"Established the central question of how p53 enforces growth suppression by identifying p21/WAF1 as a direct p53 transcriptional target and growth-suppressive effector.","evidence":"Yeast enhancer trap, promoter-reporter assay, and cDNA overexpression in human tumor cells","pmids":["8242752"],"confidence":"High","gaps":["Did not define the biochemical mechanism by which p21 suppresses growth","Did not address p53-independent regulation"]},{"year":1994,"claim":"Showed p21 induction is not exclusively a p53/DNA-damage response, separating mitogen-driven immediate-early induction from damage-induced p53-dependent induction.","evidence":"p53-null MEFs with growth-factor stimulation, gamma-irradiation, and mRNA kinetics with cycloheximide","pmids":["8012956"],"confidence":"High","gaps":["Did not identify the transcription factors mediating growth-factor induction","Functional consequence of immediate-early induction unresolved"]},{"year":1995,"claim":"Resolved how a single inhibitor blocks the cell cycle by dissecting two independent inhibitory domains—an N-terminal CDK-inhibitory module and a C-terminal PCNA-binding module.","evidence":"Domain deletion/overexpression in mammalian cells plus in vitro PCNA-dependent replication and CDK inhibition assays","pmids":["7753174"],"confidence":"High","gaps":["Did not quantify PCNA binding affinity","Did not establish which domain dominates in physiological contexts"]},{"year":1995,"claim":"Extended p21 function beyond proliferation control to terminal differentiation, showing p53-independent expression across lineages and that MyoD is sufficient but dispensable for myogenic induction.","evidence":"p53-null and MyoD/myogenin double-knockout mice with in situ hybridization and developmental expression analysis","pmids":["7863329"],"confidence":"High","gaps":["Did not identify the factors driving p21 in non-myogenic differentiation","Causal role of p21 in differentiation vs. correlation not fully resolved"]},{"year":1996,"claim":"Defined the molecular basis of C-terminal replication inhibition by showing p21 binds PCNA at nanomolar affinity and competitively displaces Fen1 from the replication complex.","evidence":"In vitro Kd measurement, co-IP in cell extracts, and in vivo overexpression","pmids":["8876181"],"confidence":"High","gaps":["Did not address competition with other PCNA partners in vivo","Did not link Fen1 displacement to specific repair outcomes"]},{"year":1997,"claim":"Connected upstream developmental signaling to p21-mediated CDK2 inactivation, showing Gax induces p21 p53-independently and that p21 is required for Gax-driven arrest.","evidence":"Adenoviral Gax overexpression, p21-null fibroblasts, CDK2 activity assay, and co-IP","pmids":["9224717"],"confidence":"Medium","gaps":["Mechanism of Gax-driven p21 transcription not defined","Single-lab study"]},{"year":1997,"claim":"Refined the N-terminal mechanism by showing p21 and Cdc25A compete for cyclin-CDK complexes through the Cy motif, establishing a regulatory tug-of-war over CDK activation.","evidence":"In vitro binding, Cy-motif mutagenesis, competitive peptide inhibition, and Xenopus extract replication assay","pmids":["9234691"],"confidence":"High","gaps":["In vivo stoichiometry of the competition not established","Did not connect to specific physiological arrest signals"]},{"year":1998,"claim":"Identified a naturally occurring C-terminally truncated p21 variant lacking PCNA-binding and NLS, linking loss of these domains to monomeric, cytoplasmic, non-inhibitory p21 in transformed cells.","evidence":"SDS-PAGE mobility shift, co-IP with Cdk2/PCNA, gel filtration, and subcellular fractionation","pmids":["9546435"],"confidence":"Medium","gaps":["Protease/mechanism generating p21delta not identified","Functional contribution to transformation not directly tested"]},{"year":1999,"claim":"Mapped a transcriptional route for oncogenic Ras to p21 via Sp1-binding promoter elements and a separate MAPK-dependent posttranscriptional route.","evidence":"Conditional Ras expression, promoter deletion/point mutants, luciferase reporter, and EMSA","pmids":["10597223"],"confidence":"Medium","gaps":["Did not resolve the posttranscriptional MAPK mechanism","Single-lab study"]},{"year":2000,"claim":"Established p21 as the physiological switch for hematopoietic stem cell quiescence, defining an organismal role distinct from acute damage responses.","evidence":"p21-knockout mice, serial bone marrow transplantation, cell cycle analysis, and myelotoxic injury","pmids":["10710306"],"confidence":"High","gaps":["Upstream signals setting p21 levels in HSCs not defined","Did not address localization control in stem cells"]},{"year":2000,"claim":"Revealed reciprocal p21–c-Myc antagonism, showing p21 both inhibits PCNA-dependent polymerase delta and blocks c-Myc-Max transcriptional activation.","evidence":"Reciprocal co-IP, in vitro DNA synthesis assay, EMSA, and reporter assay","pmids":["10744738"],"confidence":"Medium","gaps":["In vivo significance of the Myc interaction not established","Single-lab study"]},{"year":2001,"claim":"Identified phosphorylation-driven relocalization as the basis of p21's dual identity: Akt phosphorylates Thr145 to send p21 to the cytoplasm and convert it into a growth promoter.","evidence":"Co-IP, dominant-negative Akt rescue, phosphorylation mapping, fractionation/IF in HER-2/neu cells","pmids":["11231573"],"confidence":"High","gaps":["Did not define cytoplasmic effectors mediating growth promotion","Quantitative contribution vs. nuclear pool unclear"]},{"year":2002,"claim":"Generalized Thr145-driven relocalization by identifying Pim-1 as a second kinase that phosphorylates this site and drives cytoplasmic p21.","evidence":"In vitro kinase assay, pull-down, co-transfection with WT/kinase-dead Pim-1, phosphoamino acid analysis, and localization","pmids":["12431783"],"confidence":"High","gaps":["Relative contribution of Akt vs. Pim-1 in vivo not resolved","Downstream cytoplasmic function not addressed"]},{"year":2003,"claim":"Placed GADD34 upstream of p21 by showing it enhances p53 Ser15 phosphorylation and p53-dependent p21 transcription.","evidence":"GADD34 transfection, p53 Ser15 phosphorylation assay, p21 promoter reporter, and GADD34-null MEFs","pmids":["14635196"],"confidence":"Medium","gaps":["Mechanism by which GADD34 promotes p53 phosphorylation not detailed","Single-lab study"]},{"year":2004,"claim":"Showed chromatin remodeling drives p21 induction, with BRG1/SWI-SNF activating pRb through p21 upregulation to enforce growth arrest and senescence.","evidence":"BRG1 expression, p21 promoter analysis, CDK/cyclin measurements, and senescence/growth-arrest assays","pmids":["14729964"],"confidence":"Medium","gaps":["Direct BRG1 occupancy at the p21 promoter not shown","Single-lab study"]},{"year":2004,"claim":"Demonstrated proteolytic regulation of p21 localization, with proteinase 3 cleavage between Thr80/Gly81 stripping nuclear p21 and promoting endothelial apoptosis.","evidence":"Immunoblotting, IF, flow cytometry, PR3 treatment of HUVECs, and cleavage-site mapping","pmids":["14675038"],"confidence":"Medium","gaps":["Physiological context of PR3-mediated cleavage limited to endothelium","In vivo relevance not established"]},{"year":2005,"claim":"Defined degradative control of p21 by showing SCF(Skp2) ubiquitinates C-terminal lysines in a manner requiring cyclin E-CDK2 docking through the RXL and FNF motifs.","evidence":"In vitro and in vivo ubiquitination assays with mutagenesis of recruitment motifs and lysines","pmids":["16262255"],"confidence":"High","gaps":["Cell-cycle timing of Skp2-mediated turnover not fully defined","Other ubiquitin ligases not excluded"]},{"year":2005,"claim":"Added a lineage-specific transcriptional inducer by showing Mitf activates p21 and induces Rb-dependent G1 arrest, cooperating with Rb1.","evidence":"Mitf overexpression, p21 promoter reporter, Mitf-Rb1 co-IP, and cell cycle analysis","pmids":["15716956"],"confidence":"Medium","gaps":["Direct Mitf occupancy at the endogenous promoter not shown","Single-lab study"]},{"year":2007,"claim":"Uncovered p53-independent control of Rb by p21, showing ectopic p21 drives both Rb dephosphorylation and proteasomal Rb depletion.","evidence":"Ectopic p21 in multiple lines, proteasome inhibitor, p21 shRNA, and transdominant p53 inhibitor","pmids":["17486059"],"confidence":"Medium","gaps":["Ubiquitin ligase mediating Rb depletion not identified","Single-lab study"]},{"year":2009,"claim":"Extended p21's arrest function into G2 by showing it sustains DNA damage-induced G2 arrest through proteasomal degradation of cyclin B1.","evidence":"p21-null cells, DNA damage, cyclin B1 measurement, proteasome inhibitor rescue, and cell cycle analysis","pmids":["19158493"],"confidence":"Medium","gaps":["Mechanism linking p21 to cyclin B1 degradation not defined","Single-lab study"]},{"year":2009,"claim":"Defined epigenetic silencing of p21 by CTIP2-recruited HDACs and SUV39H1 deposition of H3K9me3 at the promoter.","evidence":"ChIP, SUV39H1 inhibitor (chaetocin), promoter reporter, and co-IP of CTIP2 with HDACs/SUV39H1","pmids":["19581932"],"confidence":"Medium","gaps":["Signals recruiting CTIP2 to the promoter not defined","Single-lab study"]},{"year":2012,"claim":"Placed Trim71 upstream of Cdkn1a in ESC cell-cycle control, repressing p21 via Argonaute2/miRNA to promote the G1-S transition.","evidence":"Trim71-Ago2 co-IP, Trim71 knockdown, Cdkn1a reporter, cell cycle analysis, and epistasis rescue by Cdkn1a depletion","pmids":["22735451"],"confidence":"Medium","gaps":["Specific miRNAs targeting Cdkn1a not identified","Single-lab study"]},{"year":2013,"claim":"Linked p21 turnover to apoptosis decisions, showing Chk1-activated Lats2 phosphorylates S146 after UV to degrade p21 and de-repress caspase-3.","evidence":"In vitro kinase assay, site mutagenesis, UV irradiation, caspase activity assays, and overexpression/knockdown","pmids":["23886938"],"confidence":"Medium","gaps":["Generality beyond UV stress not established","Single-lab study"]},{"year":2016,"claim":"Showed S130 phosphorylation by Cdk1/cyclin B1 during mitosis tunes p21 stability and CDK affinity to ensure proper mitotic duration and chromosome segregation.","evidence":"In vitro kinase assay, S130A mutant, mitotic duration, and chromosome segregation analysis","pmids":["27384476"],"confidence":"Medium","gaps":["In vivo phenotype of S130 phosphorylation loss not assessed in animals","Single-lab study"]},{"year":2016,"claim":"Identified Cdk5 as a Cdk2-independent S130 kinase that degrades nuclear p21 in S-phase to promote cancer cell growth.","evidence":"In vitro kinase assay, S130A mutant, proteasome inhibitor, growth assay, fractionation, and clinical correlation","pmids":["27909065"],"confidence":"Medium","gaps":["Relationship between Cdk5- and Cdk1-mediated S130 phosphorylation not resolved","Single-lab study"]},{"year":2016,"claim":"Demonstrated a non-canonical survival role, with p21 required for Langerhans cell survival, DNA repair, migration, and Treg induction after irradiation.","evidence":"Cdkn1a-/- mice, IR, apoptosis and DNA-damage markers, MHC-II expression, lymph node migration, and Treg quantification","pmids":["26343536"],"confidence":"Medium","gaps":["Molecular basis of the survival/repair function in LCs not defined","Single-lab study"]},{"year":2021,"claim":"Added RNA-level control by showing NSUN2-deposited m5C and the ALYREF reader promote CDKN1A mRNA nuclear export and p21 protein expression.","evidence":"NSUN2 knockdown, ALYREF-CDKN1A RIP, nuclear/cytoplasmic fractionation, Western blot, and cell cycle analysis","pmids":["34570675"],"confidence":"Medium","gaps":["m5C site mapping on CDKN1A mRNA not detailed","Single-lab study"]},{"year":null,"claim":"It remains unresolved how the many competing inputs—transcriptional inducers/silencers, RNA-export control, multi-site phosphorylation, ubiquitination, and proteolysis—are quantitatively integrated to set the nuclear vs. cytoplasmic p21 pool that decides between tumor suppression and survival in a given cell.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model of p21 localization control","Context-dependent dominance of competing kinases/ligases unknown","Cytoplasmic anti-apoptotic effectors not molecularly defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,8,9]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[10]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[5,9]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,6,27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,6,19,27]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,8,9,12,15]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[1,5]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,17,18,20,21]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[11,14,16,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14,19]}],"complexes":["SCF(Skp2) ubiquitin ligase (substrate)","cyclin E-Cdk2 complex (binding partner)","PCNA (binding partner)"],"partners":["TP53","PCNA","FEN1","CDK2","CDC25A","AKT1","PIM1","SKP2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P38936","full_name":"Cyclin-dependent kinase inhibitor 1","aliases":["CDK-interacting protein 1","Melanoma differentiation-associated protein 6","MDA-6","p21"],"length_aa":164,"mass_kda":18.1,"function":"Plays an important role in controlling cell cycle progression and DNA damage-induced G2 arrest (PubMed:9106657). Involved in p53/TP53 mediated inhibition of cellular proliferation in response to DNA damage. Also involved in p53-independent DNA damage-induced G2 arrest mediated by CREB3L1 in astrocytes and osteoblasts (By similarity). Binds to and inhibits cyclin-dependent kinase activity, preventing phosphorylation of critical cyclin-dependent kinase substrates and blocking cell cycle progression. Functions in the nuclear localization and assembly of cyclin D-CDK4 complex and promotes its kinase activity towards RB1. At higher stoichiometric ratios, inhibits the kinase activity of the cyclin D-CDK4 complex. Inhibits DNA synthesis by DNA polymerase delta by competing with POLD3 for PCNA binding (PubMed:11595739). Negatively regulates the CDK4- and CDK6-driven phosphorylation of RB1 in keratinocytes, thereby resulting in the release of E2F1 and subsequent transcription of E2F1-driven G1/S phase promoting genes (By similarity)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P38936/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CDKN1A","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CDKN1A","total_profiled":1310},"omim":[{"mim_id":"621287","title":"LIN37 DREAM MUVB CORE COMPLEX COMPONENT; LIN37","url":"https://www.omim.org/entry/621287"},{"mim_id":"621239","title":"INTEGRATOR COMPLEX SUBUNIT 15; INTS15","url":"https://www.omim.org/entry/621239"},{"mim_id":"620974","title":"ZINC FINGER PROTEIN 862; ZNF862","url":"https://www.omim.org/entry/620974"},{"mim_id":"620896","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 42; LRRC42","url":"https://www.omim.org/entry/620896"},{"mim_id":"620341","title":"WD REPEAT-CONTAINING PROTEIN 75; WDR75","url":"https://www.omim.org/entry/620341"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nuclear bodies","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CDKN1A"},"hgnc":{"alias_symbol":["P21","CIP1","WAF1","SDI1","CAP20","p21CIP1","p21Cip1/Waf1","p21"],"prev_symbol":["CDKN1"]},"alphafold":{"accession":"P38936","domains":[{"cath_id":"4.10.365.10","chopping":"26-76","consensus_level":"high","plddt":92.2406,"start":26,"end":76}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P38936","model_url":"https://alphafold.ebi.ac.uk/files/AF-P38936-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P38936-F1-predicted_aligned_error_v6.png","plddt_mean":69.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CDKN1A","jax_strain_url":"https://www.jax.org/strain/search?query=CDKN1A"},"sequence":{"accession":"P38936","fasta_url":"https://rest.uniprot.org/uniprotkb/P38936.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P38936/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P38936"}},"corpus_meta":[{"pmid":"8242752","id":"PMC_8242752","title":"WAF1, a potential mediator of p53 tumor suppression.","date":"1993","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8242752","citation_count":8153,"is_preprint":false},{"pmid":"10710306","id":"PMC_10710306","title":"Hematopoietic stem cell quiescence maintained by p21cip1/waf1.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10710306","citation_count":1053,"is_preprint":false},{"pmid":"7863329","id":"PMC_7863329","title":"p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7863329","citation_count":1048,"is_preprint":false},{"pmid":"11231573","id":"PMC_11231573","title":"Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.","date":"2001","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11231573","citation_count":932,"is_preprint":false},{"pmid":"8012956","id":"PMC_8012956","title":"Induction of WAF1/CIP1 by a p53-independent pathway.","date":"1994","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8012956","citation_count":889,"is_preprint":false},{"pmid":"7753174","id":"PMC_7753174","title":"Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7753174","citation_count":536,"is_preprint":false},{"pmid":"11880176","id":"PMC_11880176","title":"Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.","date":"2002","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/11880176","citation_count":365,"is_preprint":false},{"pmid":"20190813","id":"PMC_20190813","title":"Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region.","date":"2010","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/20190813","citation_count":319,"is_preprint":false},{"pmid":"15716956","id":"PMC_15716956","title":"Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15716956","citation_count":308,"is_preprint":false},{"pmid":"8756825","id":"PMC_8756825","title":"P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis.","date":"1996","source":"American journal of respiratory and critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8756825","citation_count":297,"is_preprint":false},{"pmid":"8957006","id":"PMC_8957006","title":"The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8957006","citation_count":287,"is_preprint":false},{"pmid":"17412634","id":"PMC_17412634","title":"Histone deacetylase inhibitors: signalling towards p21cip1/waf1.","date":"2007","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17412634","citation_count":228,"is_preprint":false},{"pmid":"31438587","id":"PMC_31438587","title":"The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31438587","citation_count":224,"is_preprint":false},{"pmid":"10666414","id":"PMC_10666414","title":"Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1).","date":"2000","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10666414","citation_count":209,"is_preprint":false},{"pmid":"12431783","id":"PMC_12431783","title":"Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12431783","citation_count":173,"is_preprint":false},{"pmid":"7522462","id":"PMC_7522462","title":"Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells.","date":"1994","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/7522462","citation_count":170,"is_preprint":false},{"pmid":"9224717","id":"PMC_9224717","title":"p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene.","date":"1997","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9224717","citation_count":155,"is_preprint":false},{"pmid":"21815189","id":"PMC_21815189","title":"p21Cip1/Waf1 protein and its function based on a subcellular localization [corrected].","date":"2011","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21815189","citation_count":143,"is_preprint":false},{"pmid":"22735451","id":"PMC_22735451","title":"Trim71 cooperates with microRNAs to repress Cdkn1a expression and promote embryonic stem cell proliferation.","date":"2012","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/22735451","citation_count":131,"is_preprint":false},{"pmid":"8876181","id":"PMC_8876181","title":"p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8876181","citation_count":121,"is_preprint":false},{"pmid":"9179052","id":"PMC_9179052","title":"Expression of p21 (waf1/cip1/sdi1), but not p53 protein, is a factor in the survival of patients with advanced gastric carcinoma.","date":"1997","source":"Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9179052","citation_count":119,"is_preprint":false},{"pmid":"10744738","id":"PMC_10744738","title":"Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10744738","citation_count":116,"is_preprint":false},{"pmid":"26343536","id":"PMC_26343536","title":"CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation.","date":"2015","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26343536","citation_count":112,"is_preprint":false},{"pmid":"8997395","id":"PMC_8997395","title":"The p53-independent activation of transcription of p21 WAF1/CIP1/SDI1 after acute renal failure.","date":"1996","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/8997395","citation_count":107,"is_preprint":false},{"pmid":"24858045","id":"PMC_24858045","title":"Less understood issues: p21(Cip1) in mitosis and its therapeutic potential.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24858045","citation_count":103,"is_preprint":false},{"pmid":"9390024","id":"PMC_9390024","title":"Multiple pathways control cell growth and transformation: overlapping and independent activities of p53 and p21Cip1/WAF1/Sdi1.","date":"1997","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/9390024","citation_count":102,"is_preprint":false},{"pmid":"19581932","id":"PMC_19581932","title":"p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19581932","citation_count":101,"is_preprint":false},{"pmid":"14729964","id":"PMC_14729964","title":"BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14729964","citation_count":100,"is_preprint":false},{"pmid":"9234691","id":"PMC_9234691","title":"p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9234691","citation_count":98,"is_preprint":false},{"pmid":"12727815","id":"PMC_12727815","title":"CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12727815","citation_count":96,"is_preprint":false},{"pmid":"10692435","id":"PMC_10692435","title":"DNA methyltransferase inhibition induces the transcription of the tumor suppressor p21(WAF1/CIP1/sdi1).","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10692435","citation_count":94,"is_preprint":false},{"pmid":"26240282","id":"PMC_26240282","title":"Aurora B Overexpression Causes Aneuploidy and p21Cip1 Repression during Tumor Development.","date":"2015","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26240282","citation_count":93,"is_preprint":false},{"pmid":"17170062","id":"PMC_17170062","title":"A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning.","date":"2006","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17170062","citation_count":92,"is_preprint":false},{"pmid":"10361114","id":"PMC_10361114","title":"Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis.","date":"1999","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10361114","citation_count":91,"is_preprint":false},{"pmid":"26876176","id":"PMC_26876176","title":"Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26876176","citation_count":89,"is_preprint":false},{"pmid":"15650400","id":"PMC_15650400","title":"Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death.","date":"2005","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/15650400","citation_count":87,"is_preprint":false},{"pmid":"12046058","id":"PMC_12046058","title":"Effects of histone acetylation and DNA methylation on p21( WAF1) regulation.","date":"2002","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12046058","citation_count":84,"is_preprint":false},{"pmid":"12138399","id":"PMC_12138399","title":"Novel targets of Akt, p21(Cipl/WAF1), and MDM2.","date":"2002","source":"Seminars in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/12138399","citation_count":76,"is_preprint":false},{"pmid":"7496159","id":"PMC_7496159","title":"Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas.","date":"1995","source":"Melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/7496159","citation_count":76,"is_preprint":false},{"pmid":"19158493","id":"PMC_19158493","title":"p21Cip1/WAF1 mediates cyclin B1 degradation in response to DNA damage.","date":"2009","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/19158493","citation_count":72,"is_preprint":false},{"pmid":"16262255","id":"PMC_16262255","title":"Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection.","date":"2005","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16262255","citation_count":71,"is_preprint":false},{"pmid":"34035185","id":"PMC_34035185","title":"Cdkn1a transcript variant 2 is a marker of aging and cellular senescence.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/34035185","citation_count":70,"is_preprint":false},{"pmid":"9891946","id":"PMC_9891946","title":"Cell cycle profiles and expressions of p21CIP1 AND P27KIP1 during myocyte development.","date":"1998","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/9891946","citation_count":68,"is_preprint":false},{"pmid":"17486059","id":"PMC_17486059","title":"p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17486059","citation_count":65,"is_preprint":false},{"pmid":"19449443","id":"PMC_19449443","title":"p21(WAF1/CIP1) and cancer: a shifting paradigm?","date":"2009","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19449443","citation_count":65,"is_preprint":false},{"pmid":"10597223","id":"PMC_10597223","title":"Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10597223","citation_count":61,"is_preprint":false},{"pmid":"15596565","id":"PMC_15596565","title":"Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.","date":"2004","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15596565","citation_count":60,"is_preprint":false},{"pmid":"34570675","id":"PMC_34570675","title":"mRNA m5C controls adipogenesis by promoting CDKN1A mRNA export and translation.","date":"2021","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/34570675","citation_count":57,"is_preprint":false},{"pmid":"35806061","id":"PMC_35806061","title":"Revisiting the Function of p21CDKN1A in DNA Repair: The Influence of Protein Interactions and Stability.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35806061","citation_count":56,"is_preprint":false},{"pmid":"8601638","id":"PMC_8601638","title":"Expression of p21(WAF1/CIP1/SDI1) and p53 in apoptotic cells in the adrenal cortex and induction by ischemia/reperfusion injury.","date":"1996","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8601638","citation_count":55,"is_preprint":false},{"pmid":"17682292","id":"PMC_17682292","title":"FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17682292","citation_count":55,"is_preprint":false},{"pmid":"8939883","id":"PMC_8939883","title":"Novel form of p21(WAF1/CIP1/SDI1) protein in phorbol ester-induced G2/M arrest.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8939883","citation_count":55,"is_preprint":false},{"pmid":"10082476","id":"PMC_10082476","title":"Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.","date":"1999","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/10082476","citation_count":55,"is_preprint":false},{"pmid":"8912833","id":"PMC_8912833","title":"p53 and p21(WAF1/CIP1/SDI1) gene products in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction.","date":"1996","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/8912833","citation_count":55,"is_preprint":false},{"pmid":"14675038","id":"PMC_14675038","title":"Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis.","date":"2004","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/14675038","citation_count":52,"is_preprint":false},{"pmid":"27878260","id":"PMC_27878260","title":"miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/27878260","citation_count":52,"is_preprint":false},{"pmid":"12702511","id":"PMC_12702511","title":"Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12702511","citation_count":52,"is_preprint":false},{"pmid":"10733944","id":"PMC_10733944","title":"Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10733944","citation_count":51,"is_preprint":false},{"pmid":"14635196","id":"PMC_14635196","title":"GADD34 induces p53 phosphorylation and p21/WAF1 transcription.","date":"2003","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14635196","citation_count":50,"is_preprint":false},{"pmid":"9546435","id":"PMC_9546435","title":"Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9546435","citation_count":49,"is_preprint":false},{"pmid":"19353769","id":"PMC_19353769","title":"Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3.","date":"2009","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/19353769","citation_count":46,"is_preprint":false},{"pmid":"17277135","id":"PMC_17277135","title":"p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17277135","citation_count":46,"is_preprint":false},{"pmid":"26402653","id":"PMC_26402653","title":"MiR-423-3p enhances cell growth through inhibition of p21Cip1/Waf1 in colorectal cancer.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26402653","citation_count":45,"is_preprint":false},{"pmid":"38139316","id":"PMC_38139316","title":"CDKN1A/p21 in Breast Cancer: Part of the Problem, or Part of the Solution?","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38139316","citation_count":42,"is_preprint":false},{"pmid":"26621850","id":"PMC_26621850","title":"Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26621850","citation_count":41,"is_preprint":false},{"pmid":"10585285","id":"PMC_10585285","title":"IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.","date":"1999","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/10585285","citation_count":40,"is_preprint":false},{"pmid":"15734884","id":"PMC_15734884","title":"EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1 upregulation and endothelial apoptosis.","date":"2005","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15734884","citation_count":39,"is_preprint":false},{"pmid":"26846300","id":"PMC_26846300","title":"SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26846300","citation_count":39,"is_preprint":false},{"pmid":"23886938","id":"PMC_23886938","title":"Lats2 phosphorylates p21/CDKN1A after UV irradiation and regulates apoptosis.","date":"2013","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23886938","citation_count":38,"is_preprint":false},{"pmid":"27384476","id":"PMC_27384476","title":"Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27384476","citation_count":37,"is_preprint":false},{"pmid":"31382612","id":"PMC_31382612","title":"p21cip1/waf1 Coordinate Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31382612","citation_count":36,"is_preprint":false},{"pmid":"9342842","id":"PMC_9342842","title":"Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein.","date":"1997","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/9342842","citation_count":35,"is_preprint":false},{"pmid":"17595776","id":"PMC_17595776","title":"Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.","date":"2007","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/17595776","citation_count":34,"is_preprint":false},{"pmid":"20955243","id":"PMC_20955243","title":"The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.","date":"2010","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/20955243","citation_count":34,"is_preprint":false},{"pmid":"31514410","id":"PMC_31514410","title":"Epigenetic Regulation of p21cip1/waf1 in Human Cancer.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31514410","citation_count":32,"is_preprint":false},{"pmid":"15877047","id":"PMC_15877047","title":"Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells.","date":"2005","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15877047","citation_count":32,"is_preprint":false},{"pmid":"25483104","id":"PMC_25483104","title":"Loss of p21Cip1/CDKN1A renders cancer cells susceptible to Polo-like kinase 1 inhibition.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25483104","citation_count":32,"is_preprint":false},{"pmid":"9262510","id":"PMC_9262510","title":"Expression of p21CIP1/WAF1 in chondrocytes.","date":"1997","source":"Calcified tissue international","url":"https://pubmed.ncbi.nlm.nih.gov/9262510","citation_count":32,"is_preprint":false},{"pmid":"9651943","id":"PMC_9651943","title":"Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.","date":"1998","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/9651943","citation_count":32,"is_preprint":false},{"pmid":"26199387","id":"PMC_26199387","title":"Cellular Senescence Markers p16INK4a and p21CIP1/WAF Are Predictors of Hodgkin Lymphoma Outcome.","date":"2015","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/26199387","citation_count":32,"is_preprint":false},{"pmid":"27909065","id":"PMC_27909065","title":"Cdk5 Directly Targets Nuclear p21CIP1 and Promotes Cancer Cell Growth.","date":"2016","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/27909065","citation_count":31,"is_preprint":false},{"pmid":"10531398","id":"PMC_10531398","title":"Tumor suppressor p53 but not cGMP mediates NO-induced expression of p21(Waf1/Cip1/Sdi1) in vascular smooth muscle cells.","date":"1999","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10531398","citation_count":31,"is_preprint":false},{"pmid":"31077791","id":"PMC_31077791","title":"Fetal origin confers radioresistance on liver macrophages via p21cip1/WAF1.","date":"2019","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/31077791","citation_count":31,"is_preprint":false},{"pmid":"24828139","id":"PMC_24828139","title":"Diabetes-induced oxidative DNA damage alters p53-p21CIP1/Waf1 signaling in the rat testis.","date":"2014","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/24828139","citation_count":30,"is_preprint":false},{"pmid":"20444901","id":"PMC_20444901","title":"Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.","date":"2010","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/20444901","citation_count":30,"is_preprint":false},{"pmid":"10634797","id":"PMC_10634797","title":"Nitric oxide-induced increase in p21(Sdi1/Cip1/Waf1) expression during the cell cycle in aortic adventitial fibroblasts.","date":"2000","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10634797","citation_count":30,"is_preprint":false},{"pmid":"24599959","id":"PMC_24599959","title":"p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24599959","citation_count":29,"is_preprint":false},{"pmid":"12368211","id":"PMC_12368211","title":"Normal remodeling of the oxygen-injured lung requires the cyclin-dependent kinase inhibitor p21(Cip1/WAF1/Sdi1).","date":"2002","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12368211","citation_count":27,"is_preprint":false},{"pmid":"18441278","id":"PMC_18441278","title":"Cigarette smoke triggers code red: p21CIP1/WAF1/SDI1 switches on danger responses in the lung.","date":"2008","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18441278","citation_count":26,"is_preprint":false},{"pmid":"10432388","id":"PMC_10432388","title":"Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.","date":"1999","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/10432388","citation_count":26,"is_preprint":false},{"pmid":"10398154","id":"PMC_10398154","title":"p21(WAF1) expression and endocrine response in breast cancer.","date":"1999","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10398154","citation_count":26,"is_preprint":false},{"pmid":"8784465","id":"PMC_8784465","title":"Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines.","date":"1996","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/8784465","citation_count":26,"is_preprint":false},{"pmid":"25349305","id":"PMC_25349305","title":"Combined CDKN1A/TP53 mutation in bladder cancer is a therapeutic target.","date":"2014","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25349305","citation_count":26,"is_preprint":false},{"pmid":"26231799","id":"PMC_26231799","title":"miR-4295 promotes cell proliferation and invasion in anaplastic thyroid carcinoma via CDKN1A.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/26231799","citation_count":25,"is_preprint":false},{"pmid":"9714696","id":"PMC_9714696","title":"p53 and p21(WAF1) expression in lymphocytic thyroiditis and thyroid tumors.","date":"1998","source":"Clinical immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/9714696","citation_count":25,"is_preprint":false},{"pmid":"14985066","id":"PMC_14985066","title":"p21(Waf1/Cip1/Sdi1) mediates shear stress-dependent antiapoptotic function.","date":"2004","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/14985066","citation_count":24,"is_preprint":false},{"pmid":"24045412","id":"PMC_24045412","title":"Polymorphisms of CDKN1A gene and risk of retinoblastoma.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24045412","citation_count":24,"is_preprint":false},{"pmid":"31311187","id":"PMC_31311187","title":"Function of p21 (Cip1/Waf1/CDKN1A) in Migration and Invasion of Cancer and Trophoblastic Cells.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31311187","citation_count":24,"is_preprint":false},{"pmid":"8941927","id":"PMC_8941927","title":"Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction.","date":"1996","source":"Kidney international. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/8941927","citation_count":24,"is_preprint":false},{"pmid":"32397616","id":"PMC_32397616","title":"TFEB Modulates p21/WAF1/CIP1 during the DNA Damage Response.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32397616","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47727,"output_tokens":7102,"usd":0.124855,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16097,"output_tokens":7416,"usd":0.132942,"stage2_stop_reason":"end_turn"},"total_usd":0.257797,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"WAF1/p21 is a direct transcriptional target of wild-type p53: a p53-binding site was identified 2.4 kb upstream of WAF1 coding sequences, and the WAF1 promoter conferred p53-dependent inducibility upon a heterologous reporter gene. Introduction of WAF1 cDNA suppressed growth of human tumor cells in culture.\",\n      \"method\": \"Yeast enhancer trap, promoter-reporter assay, cDNA overexpression in human tumor cell lines\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (enhancer trap, reporter assay, functional cDNA suppression), foundational paper replicated by the field\",\n      \"pmids\": [\"8242752\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"p21Cip1 contains two functionally independent cell-cycle inhibitory domains: an N-terminal CDK-inhibitory domain and a C-terminal PCNA-binding/inhibitory domain. When separately overexpressed in mammalian cells, each domain independently prevents DNA replication.\",\n      \"method\": \"Domain deletion/overexpression in mammalian cells, in vitro PCNA-dependent DNA replication assay, CDK inhibition assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution assay combined with domain mutagenesis and in vivo overexpression, replicated across multiple labs\",\n      \"pmids\": [\"7753174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"p21/WAF1/CIP1 can be induced through a p53-independent pathway: serum and growth factors (PDGF, FGF, EGF but not insulin) induce WAF1 in quiescent p53-deficient fibroblasts as an immediate-early gene, whereas DNA damage (gamma-irradiation) induces WAF1 via a p53-dependent pathway.\",\n      \"method\": \"p53 knockout mouse embryonic fibroblasts, growth factor stimulation, gamma-irradiation, mRNA kinetics with cycloheximide\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (p53-null cells) combined with multiple stimuli and kinetic analysis; independently confirmed by other labs\",\n      \"pmids\": [\"8012956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"p21Cip1 is expressed in a p53-independent manner during terminal differentiation of multiple cell lineages (skeletal muscle, cartilage, skin, nasal epithelium). MyoD is sufficient but not necessary for p21 induction in myogenic cells, as p21 is still expressed in MyoD/myogenin double-knockout mice.\",\n      \"method\": \"p53 knockout and MyoD/myogenin knockout mice, in situ hybridization, expression analysis during development\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic knockouts combined with expression analysis in multiple tissues; widely replicated\",\n      \"pmids\": [\"7863329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Akt phosphorylates p21Cip1/WAF1 at threonine 145, resulting in cytoplasmic localization of p21 and promotion of cell growth. HER-2/neu-mediated activation of Akt drives this phosphorylation; blocking Akt with dominant-negative Akt restores nuclear localization and growth-inhibiting activity of p21.\",\n      \"method\": \"Co-IP, dominant-negative Akt expression, phosphorylation assay, subcellular fractionation/immunofluorescence, HER-2/neu-overexpressing cell lines\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, dominant-negative rescue, direct phosphorylation mapping, multiple orthogonal methods in single study\",\n      \"pmids\": [\"11231573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"p21Cip1/WAF1 competes with Fen1 for binding to PCNA: p21 binds PCNA with Kd ~10 nM (3 molecules per PCNA trimer) and prevents formation of a PCNA-Fen1 complex, thereby disrupting Fen1 recruitment to the DNA replication complex. Overexpression of p21 disrupts Fen1-PCNA interaction in vivo.\",\n      \"method\": \"In vitro binding assay (Kd measurement), co-immunoprecipitation in cell extracts, overexpression in vivo\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative in vitro binding assay plus in vivo co-IP and overexpression validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"8876181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pim-1 kinase associates with p21Cip1/WAF1 and phosphorylates it at Thr145 in vivo, resulting in cytoplasmic localization of p21. Co-transfection of kinase-dead Pim-1 results in nuclear localization of p21, whereas wild-type Pim-1 drives cytoplasmic localization.\",\n      \"method\": \"In vitro kinase assay, pull-down assay, immunoprecipitation, co-transfection with wild-type and kinase-dead Pim-1, phosphoamino acid analysis, subcellular localization\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with site identification, confirmed in vivo by co-transfection rescue and subcellular localization, multiple methods in single lab\",\n      \"pmids\": [\"12431783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p21cip1/waf1 functions as the molecular switch governing hematopoietic stem cell (HSC) quiescence: p21-knockout mice show increased HSC proliferation and number under homeostasis, and serial transplantation of p21-/- bone marrow leads to HSC exhaustion and hematopoietic failure under stress.\",\n      \"method\": \"p21 knockout mice, serial bone marrow transplantation, cell cycle analysis, myelotoxic injury model\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic knockout with specific in vivo phenotypic readouts, serial transplantation, widely cited and replicated\",\n      \"pmids\": [\"10710306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"p21CIP1 mediates G1-S cell cycle arrest downstream of the homeodomain protein Gax: Gax overexpression induces p53-independent upregulation of p21, leading to p21 association with cdk2 complexes and decreased cdk2 activity. Fibroblasts deficient in p21 are not susceptible to growth inhibition or cdk2 inactivation by Gax.\",\n      \"method\": \"Recombinant adenovirus-mediated Gax overexpression, p21 knockout fibroblasts, cdk2 activity assay, co-immunoprecipitation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (p21-null cells) combined with biochemical CDK assay and co-IP, single lab\",\n      \"pmids\": [\"9224717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"p21CIP1 and Cdc25A compete for binding to cyclin-cdk complexes via a cyclin-binding Cy motif. A p21-derived Cy-motif peptide competitively disrupts Cdc25A-cyclin-cdk2 association and inhibits cdk2 dephosphorylation. p21 inhibits Cdc25A-mediated cyclin E-cdk2 association, while Cdc25A protects cyclin-cdk from p21 inhibition.\",\n      \"method\": \"In vitro binding assay, Cy-motif mutagenesis, competitive peptide inhibition, Xenopus egg extract DNA replication assay, co-immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with mutational analysis and competitive peptide, plus Xenopus extract assay, multiple orthogonal methods\",\n      \"pmids\": [\"9234691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"c-Myc directly binds the C-terminal region of p21 and partially relieves p21-mediated inhibition of PCNA-dependent DNA polymerase delta activity. Conversely, p21 binding to the Myc box II region of c-Myc blocks c-Myc-Max complex formation on E-box elements, suppressing c-Myc transcriptional activation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro DNA synthesis assay, electrophoretic mobility shift assay (EMSA), transcription reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus functional biochemical assays (DNA synthesis, EMSA), single lab\",\n      \"pmids\": [\"10744738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"SCF(Skp2) ubiquitin ligase ubiquitinates p21Cip1/WAF1 in a manner that requires functional interaction of p21 with the cyclin E-Cdk2 complex. Mutation of both the cyclin E recruitment motif (RXL) and the Cdk2-binding motif (FNF) at the N-terminus of p21 abolishes ubiquitination; ubiquitination occurs at four C-terminal lysine residues.\",\n      \"method\": \"In vitro ubiquitination assay, site-directed mutagenesis of p21, co-immunoprecipitation, in vivo ubiquitination assay\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstituted ubiquitination assay with mutagenesis of substrate recruitment motifs and ubiquitination sites, confirmed in vivo\",\n      \"pmids\": [\"16262255\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"p21Cip1/WAF1 mediates DNA damage-induced G2 cell cycle arrest by promoting proteasomal degradation of cyclin B1. Cells lacking p21 or unable to upregulate p21 fail to downregulate cyclin B1 after DNA damage, cannot sustain G2 arrest, and accumulate >4N DNA content.\",\n      \"method\": \"p21-null cells, DNA damage treatment, cyclin B1 protein level analysis, proteasome inhibitor rescue, cell cycle analysis\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (p21-null) combined with pharmacological rescue (proteasome inhibitor), single lab\",\n      \"pmids\": [\"19158493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"p21(Waf1) promotes proteasomal degradation of the retinoblastoma protein Rb in a p53-independent manner: ectopic p21 in HT1080 and HCT116 cells causes both Rb dephosphorylation (activation) and Rb protein depletion via proteasome. Rb depletion after DNA damage does not occur in the absence of p21.\",\n      \"method\": \"Ectopic p21 expression, p53-independent context, proteasome inhibitor, p21 shRNA knockdown, transdominant p53 inhibitor\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell lines, pharmacological (proteasome inhibitor) and genetic (shRNA) approaches, single lab\",\n      \"pmids\": [\"17486059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Lats2 kinase phosphorylates p21/CDKN1A at S146 in response to UV irradiation (after being activated by Chk1 phosphorylation at S835). This phosphorylation induces degradation of p21, releases procaspase-3 inhibition, and promotes apoptosis via caspase-3 and caspase-9 activation.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, UV irradiation, caspase activity assay, overexpression and knockdown\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with site identification plus functional apoptosis readout, single lab\",\n      \"pmids\": [\"23886938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cdk1/cyclin B1 phosphorylates p21 at S130 during mitosis, which reduces p21 stability and its binding affinity to Cdk1/cyclin B1. Interfering with this phosphorylation (S130A mutant) results in extended mitotic duration and defective chromosome segregation.\",\n      \"method\": \"In vitro kinase assay, S130A phospho-mutant expression, mitotic duration measurement, chromosome segregation analysis\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with phospho-site mutagenesis and functional mitotic readout, single lab\",\n      \"pmids\": [\"27384476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Cdk5 directly phosphorylates p21CIP1 at S130 in a Cdk2-independent manner, triggering proteasome-dependent degradation of nuclear p21 primarily in S-phase and promoting cancer cell growth. S130A-p21 mutant blocks both p21 degradation and Cdk5-induced cancer cell growth increase.\",\n      \"method\": \"In vitro kinase assay, S130A mutant, proteasome inhibitor, cell growth assay, subcellular fractionation, clinical sample correlation\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis and functional growth assay, single lab\",\n      \"pmids\": [\"27909065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"BRG1-containing SWI/SNF complexes activate pRb by inducing its hypophosphorylation through upregulation of p21CIP1/WAF1/SDI1. The physical interaction between BRG1 and pRb is not required for cell growth arrest or E2F target gene repression; instead, BRG1 acts via p21 induction to activate pRb. p21 upregulation by BRG1 is necessary to induce growth arrest and cell senescence.\",\n      \"method\": \"BRG1 expression in cells, p21 promoter analysis, CDK2/cyclin E/cyclin D measurement, cell senescence assay, growth arrest assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional epistasis via expression and genetic approaches, single lab with multiple phenotypic readouts\",\n      \"pmids\": [\"14729964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CTIP2 recruits histone deacetylases and the methyltransferase SUV39H1 to the p21(WAF1) promoter, silencing p21 transcription via H3K9 trimethylation. Inhibition of SUV39H1 with chaetocin reduces H3K9me3 at the p21 promoter and stimulates p21 expression.\",\n      \"method\": \"ChIP assay, SUV39H1 inhibitor treatment, promoter reporter assay, co-immunoprecipitation of CTIP2 with HDACs and SUV39H1\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating recruitment, pharmacological inhibitor, and reporter assay, single lab\",\n      \"pmids\": [\"19581932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Proteinase 3 (PR3) cleaves p21 between Thr80 and Gly81 in endothelial cells, causing loss of nuclear p21, cytoplasmic sequestration, and depletion of p21 from cyclin/CDK complexes, thereby promoting endothelial cell apoptosis. Granzyme B cleaves p21 at a different site (between Asp62 and Phe63).\",\n      \"method\": \"Immunoblotting, immunofluorescence, flow cytometry, treatment of HUVECs with PR3, cleavage site mapping\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cleavage with site identification, functional loss-of-nuclear-localization and apoptosis readout, single lab\",\n      \"pmids\": [\"14675038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Mitf (microphthalmia-associated transcription factor) activates p21(Cip1) gene expression and induces G1 cell-cycle arrest in a p21-dependent manner. Cooperation between Mitf and retinoblastoma protein Rb1 potentiates Mitf-mediated transcriptional activation. Mitf-mediated p21 induction leads to Rb1 hypophosphorylation.\",\n      \"method\": \"Mitf overexpression, p21 promoter reporter assay, co-immunoprecipitation of Mitf with Rb1, cell cycle analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter, protein-protein interaction, and functional cell cycle assay, single lab\",\n      \"pmids\": [\"15716956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ras induces p21Cip1/Waf1 transcriptionally through Sp1-binding sites (positions -83 to -54) in the p21 promoter. Mutation of both Sp1-binding sites 2 and 4 abolishes Ras-induced promoter activity. In conditional Ras-expressing cells, p21 induction is posttranscriptional via the MAPK pathway.\",\n      \"method\": \"Conditional Ras expression, p21 promoter deletion and point mutants, luciferase reporter, EMSA for Sp1/Sp3 binding\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter mutagenesis with EMSA confirmation, two model systems, single lab\",\n      \"pmids\": [\"10597223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GADD34 promotes p53 phosphorylation at Ser15 in a dose-dependent manner and enhances p21/WAF1 transcription via p53-dependent activation of the p21 promoter. p21 promoter activity is very low in GADD34-deficient MEFs and is restored by GADD34 transfection.\",\n      \"method\": \"GADD34 transfection, p53 phosphorylation assay (Ser15), p21 promoter-reporter assay, GADD34-deficient MEFs\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic (GADD34-null MEFs) and biochemical (phosphorylation assay, reporter assay), single lab\",\n      \"pmids\": [\"14635196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NSUN2-mediated m5C modification of CDKN1A mRNA promotes its nuclear export via the ALYREF m5C reader, thereby upregulating p21 protein expression. NSUN2 deficiency reduces ALYREF recognition of CDKN1A mRNA, decreases mRNA export to cytoplasm, reduces p21 translation, accelerates cell cycle, and promotes adipogenesis.\",\n      \"method\": \"NSUN2 knockdown, RIP (RNA immunoprecipitation) for ALYREF-CDKN1A mRNA interaction, mRNA nuclear/cytoplasmic fractionation, Western blot, cell cycle analysis\",\n      \"journal\": \"RNA biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP demonstrating direct ALYREF-CDKN1A mRNA interaction, fractionation showing export defect, functional rescue, single lab\",\n      \"pmids\": [\"34570675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Trim71 associates with Argonaute2 and microRNAs and represses Cdkn1a expression, promoting the G1-S transition in embryonic stem cells. Trim71 knockdown prolongs G1 phase and slows ESC proliferation; this phenotype is rescued by Cdkn1a depletion, placing Trim71 upstream of Cdkn1a in the ESC cell cycle regulatory pathway.\",\n      \"method\": \"Co-immunoprecipitation of Trim71 with Ago2, Trim71 knockdown, Cdkn1a reporter assay, cell cycle analysis, epistasis rescue by Cdkn1a depletion\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis rescue, co-IP with Ago2, and cell cycle phenotype, single lab\",\n      \"pmids\": [\"22735451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CDKN1A/p21 is required for Langerhans cell (LC) survival and DNA repair after ionizing radiation (IR). Cdkn1a-/- LCs undergo apoptosis and accumulate DNA damage after IR, and fail to upregulate MHC class II, migrate to draining lymph nodes, or induce Treg cell accumulation, unlike wild-type LCs.\",\n      \"method\": \"Cdkn1a-/- mice, IR treatment, apoptosis assay, DNA damage markers, MHC class II expression, lymph node migration assay, Treg quantification\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with multiple specific phenotypic readouts (apoptosis, DNA repair, migration, Treg induction), single lab\",\n      \"pmids\": [\"26343536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"TFEB directly regulates basal and DNA damage-induced p21/WAF1 expression in a p53-dependent manner. TFEB depletion dramatically reduces basal p21 levels; TFEB overexpression increases p21 and delays G2/M arrest during doxorubicin-induced DNA damage, promoting cell survival. Pharmacological inhibition of p21 abrogates TFEB-mediated cell protection.\",\n      \"method\": \"TFEB knockdown and overexpression, p21 promoter reporter (implied by p53-dependent effect), doxorubicin treatment, cell cycle analysis, pharmacological p21 inhibition\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, overexpression/knockdown with functional readout but limited mechanistic detail in abstract; no direct ChIP or promoter binding shown\",\n      \"pmids\": [\"32397616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A C-terminally truncated form of p21 (p21delta, lacking ~10 C-terminal amino acids including the PCNA-binding domain, second cyclin-binding domain, and NLS) is found in transformed cell lines and after high-dose UV. Unlike full-length p21, p21delta is not associated with Cdk2 or PCNA, is monomeric by gel filtration, and localizes predominantly to the cytoplasm rather than the nucleus.\",\n      \"method\": \"SDS-PAGE mobility shift analysis, co-immunoprecipitation with Cdk2 and PCNA, gel filtration chromatography, subcellular fractionation/immunofluorescence\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal biochemical methods (co-IP, gel filtration, fractionation) in single lab characterizing a naturally occurring p21 variant\",\n      \"pmids\": [\"9546435\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CDKN1A/p21 is a multifunctional cyclin-dependent kinase inhibitor that is transcriptionally induced by p53 (in response to DNA damage) and by p53-independent pathways (growth factors, differentiation signals, MAPK, Mitf, BRG1, TFEB); it inhibits CDK activity through its conserved N-terminal domain, blocks PCNA-dependent DNA replication through its C-terminal domain (competing with Fen1 for PCNA binding), undergoes cytoplasm-promoting phosphorylation at Thr145 by Akt and Pim-1 (and at S130 by Cdk1, Cdk5, and Lats2 leading to proteasomal degradation), is ubiquitinated by SCF(Skp2) at C-terminal lysines in a cyclin E-Cdk2-dependent manner, mediates G1 and G2 cell cycle arrest (including cyclin B1 degradation), controls hematopoietic stem cell quiescence, and in the cytoplasm exerts anti-apoptotic functions, with its subcellular localization being a key determinant of whether it acts as a tumor suppressor or survival factor.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"CDKN1A/p21 is a multifunctional cyclin-dependent kinase inhibitor that couples diverse anti-proliferative and stress signals to cell-cycle arrest, differentiation, and stem-cell quiescence [#0, #7]. It was first defined as a direct transcriptional target of wild-type p53, whose induction following DNA damage mediates growth suppression [#0], but it is also induced through p53-independent routes—by serum and growth factors as an immediate-early gene [#2], during terminal differentiation of multiple lineages [#3], and by an array of transcriptional regulators including Ras/Sp1 [#21], BRG1/SWI-SNF [#17], Mitf [#20], and GADD34-enhanced p53 activity [#22]; its promoter is conversely silenced by CTIP2-recruited HDACs and SUV39H1-mediated H3K9 trimethylation [#18]. p21 is built from two functionally separable inhibitory domains: an N-terminal CDK-inhibitory domain and a C-terminal PCNA-binding domain, each of which independently blocks DNA replication [#1]. Through its N-terminal cyclin (Cy/RXL) and CDK-binding motifs it engages cyclin-CDK complexes—competing with Cdc25A for these complexes [#9] and inactivating CDK2 downstream of inducers such as Gax [#8]—while its C-terminal domain binds PCNA with nanomolar affinity and displaces Fen1 from the replication complex [#5]. Beyond G1 control, p21 enforces DNA damage-induced G2 arrest by promoting proteasomal degradation of cyclin B1 [#12] and is itself phosphorylated by Cdk1/cyclin B1 at S130 to ensure proper mitotic progression and chromosome segregation [#15]. p21 abundance and localization are tightly regulated: SCF(Skp2) ubiquitinates it at C-terminal lysines in a cyclin E-CDK2-dependent manner [#11], Akt and Pim-1 phosphorylate Thr145 to drive cytoplasmic relocalization and convert p21 into a growth/survival factor [#4, #6], Cdk5 and Lats2 phosphorylate S130/S146 to trigger its degradation [#16, #14], and proteolytic cleavage by proteinase 3 strips its nuclear localization and promotes apoptosis [#19]. This localization control is the key determinant of whether p21 acts as a nuclear tumor suppressor or a cytoplasmic survival factor. Physiologically, p21 is the molecular switch governing hematopoietic stem cell quiescence, with its loss causing HSC over-proliferation and exhaustion under stress [#7], and it supports Langerhans cell survival and DNA repair after irradiation [#25].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established the central question of how p53 enforces growth suppression by identifying p21/WAF1 as a direct p53 transcriptional target and growth-suppressive effector.\",\n      \"evidence\": \"Yeast enhancer trap, promoter-reporter assay, and cDNA overexpression in human tumor cells\",\n      \"pmids\": [\"8242752\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the biochemical mechanism by which p21 suppresses growth\", \"Did not address p53-independent regulation\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Showed p21 induction is not exclusively a p53/DNA-damage response, separating mitogen-driven immediate-early induction from damage-induced p53-dependent induction.\",\n      \"evidence\": \"p53-null MEFs with growth-factor stimulation, gamma-irradiation, and mRNA kinetics with cycloheximide\",\n      \"pmids\": [\"8012956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the transcription factors mediating growth-factor induction\", \"Functional consequence of immediate-early induction unresolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Resolved how a single inhibitor blocks the cell cycle by dissecting two independent inhibitory domains—an N-terminal CDK-inhibitory module and a C-terminal PCNA-binding module.\",\n      \"evidence\": \"Domain deletion/overexpression in mammalian cells plus in vitro PCNA-dependent replication and CDK inhibition assays\",\n      \"pmids\": [\"7753174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not quantify PCNA binding affinity\", \"Did not establish which domain dominates in physiological contexts\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Extended p21 function beyond proliferation control to terminal differentiation, showing p53-independent expression across lineages and that MyoD is sufficient but dispensable for myogenic induction.\",\n      \"evidence\": \"p53-null and MyoD/myogenin double-knockout mice with in situ hybridization and developmental expression analysis\",\n      \"pmids\": [\"7863329\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the factors driving p21 in non-myogenic differentiation\", \"Causal role of p21 in differentiation vs. correlation not fully resolved\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Defined the molecular basis of C-terminal replication inhibition by showing p21 binds PCNA at nanomolar affinity and competitively displaces Fen1 from the replication complex.\",\n      \"evidence\": \"In vitro Kd measurement, co-IP in cell extracts, and in vivo overexpression\",\n      \"pmids\": [\"8876181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address competition with other PCNA partners in vivo\", \"Did not link Fen1 displacement to specific repair outcomes\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Connected upstream developmental signaling to p21-mediated CDK2 inactivation, showing Gax induces p21 p53-independently and that p21 is required for Gax-driven arrest.\",\n      \"evidence\": \"Adenoviral Gax overexpression, p21-null fibroblasts, CDK2 activity assay, and co-IP\",\n      \"pmids\": [\"9224717\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of Gax-driven p21 transcription not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Refined the N-terminal mechanism by showing p21 and Cdc25A compete for cyclin-CDK complexes through the Cy motif, establishing a regulatory tug-of-war over CDK activation.\",\n      \"evidence\": \"In vitro binding, Cy-motif mutagenesis, competitive peptide inhibition, and Xenopus extract replication assay\",\n      \"pmids\": [\"9234691\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo stoichiometry of the competition not established\", \"Did not connect to specific physiological arrest signals\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identified a naturally occurring C-terminally truncated p21 variant lacking PCNA-binding and NLS, linking loss of these domains to monomeric, cytoplasmic, non-inhibitory p21 in transformed cells.\",\n      \"evidence\": \"SDS-PAGE mobility shift, co-IP with Cdk2/PCNA, gel filtration, and subcellular fractionation\",\n      \"pmids\": [\"9546435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Protease/mechanism generating p21delta not identified\", \"Functional contribution to transformation not directly tested\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped a transcriptional route for oncogenic Ras to p21 via Sp1-binding promoter elements and a separate MAPK-dependent posttranscriptional route.\",\n      \"evidence\": \"Conditional Ras expression, promoter deletion/point mutants, luciferase reporter, and EMSA\",\n      \"pmids\": [\"10597223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not resolve the posttranscriptional MAPK mechanism\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Established p21 as the physiological switch for hematopoietic stem cell quiescence, defining an organismal role distinct from acute damage responses.\",\n      \"evidence\": \"p21-knockout mice, serial bone marrow transplantation, cell cycle analysis, and myelotoxic injury\",\n      \"pmids\": [\"10710306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals setting p21 levels in HSCs not defined\", \"Did not address localization control in stem cells\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Revealed reciprocal p21–c-Myc antagonism, showing p21 both inhibits PCNA-dependent polymerase delta and blocks c-Myc-Max transcriptional activation.\",\n      \"evidence\": \"Reciprocal co-IP, in vitro DNA synthesis assay, EMSA, and reporter assay\",\n      \"pmids\": [\"10744738\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo significance of the Myc interaction not established\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified phosphorylation-driven relocalization as the basis of p21's dual identity: Akt phosphorylates Thr145 to send p21 to the cytoplasm and convert it into a growth promoter.\",\n      \"evidence\": \"Co-IP, dominant-negative Akt rescue, phosphorylation mapping, fractionation/IF in HER-2/neu cells\",\n      \"pmids\": [\"11231573\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define cytoplasmic effectors mediating growth promotion\", \"Quantitative contribution vs. nuclear pool unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Generalized Thr145-driven relocalization by identifying Pim-1 as a second kinase that phosphorylates this site and drives cytoplasmic p21.\",\n      \"evidence\": \"In vitro kinase assay, pull-down, co-transfection with WT/kinase-dead Pim-1, phosphoamino acid analysis, and localization\",\n      \"pmids\": [\"12431783\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of Akt vs. Pim-1 in vivo not resolved\", \"Downstream cytoplasmic function not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Placed GADD34 upstream of p21 by showing it enhances p53 Ser15 phosphorylation and p53-dependent p21 transcription.\",\n      \"evidence\": \"GADD34 transfection, p53 Ser15 phosphorylation assay, p21 promoter reporter, and GADD34-null MEFs\",\n      \"pmids\": [\"14635196\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which GADD34 promotes p53 phosphorylation not detailed\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Showed chromatin remodeling drives p21 induction, with BRG1/SWI-SNF activating pRb through p21 upregulation to enforce growth arrest and senescence.\",\n      \"evidence\": \"BRG1 expression, p21 promoter analysis, CDK/cyclin measurements, and senescence/growth-arrest assays\",\n      \"pmids\": [\"14729964\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct BRG1 occupancy at the p21 promoter not shown\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrated proteolytic regulation of p21 localization, with proteinase 3 cleavage between Thr80/Gly81 stripping nuclear p21 and promoting endothelial apoptosis.\",\n      \"evidence\": \"Immunoblotting, IF, flow cytometry, PR3 treatment of HUVECs, and cleavage-site mapping\",\n      \"pmids\": [\"14675038\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological context of PR3-mediated cleavage limited to endothelium\", \"In vivo relevance not established\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined degradative control of p21 by showing SCF(Skp2) ubiquitinates C-terminal lysines in a manner requiring cyclin E-CDK2 docking through the RXL and FNF motifs.\",\n      \"evidence\": \"In vitro and in vivo ubiquitination assays with mutagenesis of recruitment motifs and lysines\",\n      \"pmids\": [\"16262255\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-cycle timing of Skp2-mediated turnover not fully defined\", \"Other ubiquitin ligases not excluded\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Added a lineage-specific transcriptional inducer by showing Mitf activates p21 and induces Rb-dependent G1 arrest, cooperating with Rb1.\",\n      \"evidence\": \"Mitf overexpression, p21 promoter reporter, Mitf-Rb1 co-IP, and cell cycle analysis\",\n      \"pmids\": [\"15716956\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Mitf occupancy at the endogenous promoter not shown\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Uncovered p53-independent control of Rb by p21, showing ectopic p21 drives both Rb dephosphorylation and proteasomal Rb depletion.\",\n      \"evidence\": \"Ectopic p21 in multiple lines, proteasome inhibitor, p21 shRNA, and transdominant p53 inhibitor\",\n      \"pmids\": [\"17486059\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Ubiquitin ligase mediating Rb depletion not identified\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended p21's arrest function into G2 by showing it sustains DNA damage-induced G2 arrest through proteasomal degradation of cyclin B1.\",\n      \"evidence\": \"p21-null cells, DNA damage, cyclin B1 measurement, proteasome inhibitor rescue, and cell cycle analysis\",\n      \"pmids\": [\"19158493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking p21 to cyclin B1 degradation not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined epigenetic silencing of p21 by CTIP2-recruited HDACs and SUV39H1 deposition of H3K9me3 at the promoter.\",\n      \"evidence\": \"ChIP, SUV39H1 inhibitor (chaetocin), promoter reporter, and co-IP of CTIP2 with HDACs/SUV39H1\",\n      \"pmids\": [\"19581932\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signals recruiting CTIP2 to the promoter not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed Trim71 upstream of Cdkn1a in ESC cell-cycle control, repressing p21 via Argonaute2/miRNA to promote the G1-S transition.\",\n      \"evidence\": \"Trim71-Ago2 co-IP, Trim71 knockdown, Cdkn1a reporter, cell cycle analysis, and epistasis rescue by Cdkn1a depletion\",\n      \"pmids\": [\"22735451\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific miRNAs targeting Cdkn1a not identified\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Linked p21 turnover to apoptosis decisions, showing Chk1-activated Lats2 phosphorylates S146 after UV to degrade p21 and de-repress caspase-3.\",\n      \"evidence\": \"In vitro kinase assay, site mutagenesis, UV irradiation, caspase activity assays, and overexpression/knockdown\",\n      \"pmids\": [\"23886938\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Generality beyond UV stress not established\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed S130 phosphorylation by Cdk1/cyclin B1 during mitosis tunes p21 stability and CDK affinity to ensure proper mitotic duration and chromosome segregation.\",\n      \"evidence\": \"In vitro kinase assay, S130A mutant, mitotic duration, and chromosome segregation analysis\",\n      \"pmids\": [\"27384476\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo phenotype of S130 phosphorylation loss not assessed in animals\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified Cdk5 as a Cdk2-independent S130 kinase that degrades nuclear p21 in S-phase to promote cancer cell growth.\",\n      \"evidence\": \"In vitro kinase assay, S130A mutant, proteasome inhibitor, growth assay, fractionation, and clinical correlation\",\n      \"pmids\": [\"27909065\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between Cdk5- and Cdk1-mediated S130 phosphorylation not resolved\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated a non-canonical survival role, with p21 required for Langerhans cell survival, DNA repair, migration, and Treg induction after irradiation.\",\n      \"evidence\": \"Cdkn1a-/- mice, IR, apoptosis and DNA-damage markers, MHC-II expression, lymph node migration, and Treg quantification\",\n      \"pmids\": [\"26343536\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the survival/repair function in LCs not defined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Added RNA-level control by showing NSUN2-deposited m5C and the ALYREF reader promote CDKN1A mRNA nuclear export and p21 protein expression.\",\n      \"evidence\": \"NSUN2 knockdown, ALYREF-CDKN1A RIP, nuclear/cytoplasmic fractionation, Western blot, and cell cycle analysis\",\n      \"pmids\": [\"34570675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"m5C site mapping on CDKN1A mRNA not detailed\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how the many competing inputs—transcriptional inducers/silencers, RNA-export control, multi-site phosphorylation, ubiquitination, and proteolysis—are quantitatively integrated to set the nuclear vs. cytoplasmic p21 pool that decides between tumor suppression and survival in a given cell.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model of p21 localization control\", \"Context-dependent dominance of competing kinases/ligases unknown\", \"Cytoplasmic anti-apoptotic effectors not molecularly defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 8, 9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [5, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 6, 27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 6, 19, 27]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 8, 9, 12, 15]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 17, 18, 20, 21]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [11, 14, 16, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14, 19]}\n    ],\n    \"complexes\": [\n      \"SCF(Skp2) ubiquitin ligase (substrate)\",\n      \"cyclin E-Cdk2 complex (binding partner)\",\n      \"PCNA (binding partner)\"\n    ],\n    \"partners\": [\n      \"TP53\",\n      \"PCNA\",\n      \"FEN1\",\n      \"CDK2\",\n      \"CDC25A\",\n      \"AKT1\",\n      \"PIM1\",\n      \"SKP2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":5,"faith_total":5,"faith_pct":100.0}}